Furosemide Injection, Solution
Product Images NDC 51662-1574

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 51662-1574). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized (51662 1574 1 Serialized Labeling)

Serialized (51662 1574 1 Serialized Labeling)
Secondary packaging label for FUROSEMIDE injection solution distributed by HF Acquisition Co LLC. The label includes serialized identification numbers, a data matrix barcode, and a note to see the manufacturer's package insert. It indicates the product is RX only and distributed from Mukilteo, WA.*
FDA Label Image

Vial (51662 1574 1 Vial Labeling)

Vial (51662 1574 1 Vial Labeling)
Furosemide Injection, USP 40 mg per 4 mL (10 mg per mL) sterile solution for intramuscular or intravenous use. The label indicates the vial is preservative-free, single dose, and 4 mL in volume. Instructions note storage at 20° to 25°C, protection from light, and warnings to discard unused or discolored solution. Labeler is Fresenius Kabi with barcode and lot/expiration details.*
FDA Label Image

51662 1574 2 Pouch Labeling

51662 1574 2 Pouch Labeling
Label for FUROSEMIDE injection, USP 40 mg per 4 mL (10 mg/mL) in a 4 mL vial. The label includes NDC 51662-1574-2, lot number 123456, and expiration date 2025-01-01. It states use for intramuscular or intravenous injection, preservative-free, with storage instructions and is manufactured by HF Acquisition Co., LLC in Mukilteo, WA.*
FDA Label Image

51662 1574 3 Case Labeling

51662 1574 3 Case Labeling
Label for FUROSEMIDE Injection USP 40 mg per 4 mL (10 mg per mL) in a 4 mL vial, box of 25, manufactured by HF Acquisition Co, LLC. The label includes the NDC 51662-1574-3, lot number, expiration date, usage instructions for IM or IV use, storage conditions, and manufacturer information in Mukilteo, WA.*
FDA Label Image

51662 1574 3 Serialized Labeling

51662 1574 3 Serialized Labeling
A small white pharmaceutical label for FUROSEMIDE injection solution distributed by HF Acquisition Co., LLC, Mukilteo, WA. The label includes a GS1 barcode and several numeric identifiers, along with the instruction to see the manufacturer's package insert. The text "RX ONLY" appears vertically on the right side.*
FDA Label Image

Description (Description)

Description (Description)
Chemical structure of furosemide, showing its molecular formula C12H11ClN2O5S and molecular weight 330.75. The diagram illustrates the arrangement of atoms and bonds in the furosemide molecule.*
FDA Label Image

Hs (Hs)

Hs (Hs)
A table listing three products with their NDC numbers, strengths, and volumes: Product 28002 with 20 mg per 2 mL strength (10 mg/mL) in a 2 mL amber vial; Product 28004 with 40 mg per 4 mL strength (10 mg/mL) in a 5 mL amber vial; Product 28010 with 100 mg per 10 mL strength (10 mg/mL) in a 10 mL amber vial.*
FDA Label Image

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.